Approval takes the share price to the $25.00+ range. Announcement could come at any time.Watch today's interview of Mannkind's CEO, Al Mann, on Bloomberg TV.http://www.bloomberg.com/video/65782516/
Sorry to spoil your fun but when Generex (GNBT.OB) gets approval for its spray inside the cheek insulin product later this year, MNKD stands to lose all of its customers.Because if you had to choose between putting something inside your cheek or something in your lung (MNKD), which would you choose?Nevertheless, we hope MNKD gets approval. Anything that helps the diabetics, right?
Options expiration on Friday will put substantial pressure on shorts to cover before the decision.
Above $13.00 by then.
FDA decision in a few days.